Collegium Pharmaceutical
COLL
174 hedge funds and large institutions have $865M invested in Collegium Pharmaceutical in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 59 reducing their positions, and 21 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 59
3% more capital invested
Capital invested by funds: $843M → $865M (+$21.8M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2.15% less ownership
Funds ownership: 113.43% → 111.28% (-2.2%)
2% less funds holding
Funds holding: 178 → 174 (-4)
19% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 21
82% less call options, than puts
Call options by funds: $239K | Put options by funds: $1.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$11.7M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$6.22M |
| 3 |
BlackRock
New York
|
+$3.71M |
| 4 |
Millennium Management
New York
|
+$3.24M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIIM
Mesirow Institutional Investment Management
Chicago,
Illinois
|
-$9.37M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$5.7M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$4.47M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$4.45M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$4.33M |
COLL Hedge Fund Activity: Q3 2023 in Review
174 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2023, worth a combined $865M — up 2.6% from $843M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of COLL and 17 opened new positions — a net loss of 4 holders — while 59 trimmed existing stakes and 74 added.
The largest buyer was Pacer Advisors, adding an estimated $11.7M. The largest seller was Mesirow Institutional Investment Management, exiting entirely with an estimated $9.37M sold.
- 174 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2023, down from 178 in Q2 2023.
- Funds reported $865M of Collegium Pharmaceutical stock for Q3 2023, up 2.6% quarter-over-quarter.
- 17 funds opened new Collegium Pharmaceutical positions in Q3 2023 and 21 closed out, a net change of -4 holders.
- The largest Collegium Pharmaceutical buyer in Q3 2023 was Pacer Advisors, an estimated $11.7M added.
- The largest Collegium Pharmaceutical seller in Q3 2023 was Mesirow Institutional Investment Management, an estimated $9.37M sold.
Based on aggregated 13F filings for Q3 2023.